Cypress Point Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-480
Closed -$236K 159
2026
Q1
$236K Buy
+480
New +$260K 0.05% 108
2021
Q1
Sell
-1,250
Closed -$582K 185
2020
Q4
$582K Buy
+1,250
New +$586K 0.88% 38

Other funds holding TMO

Cypress Point Wealth Management's TMO Position: Q2 2026 in Review

Cypress Point Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 480 shares — an estimated $236K sold.

Cypress Point Wealth Management first reported a position in TMO in Q4 2020 and held it in 2 quarters. The position peaked at $582K in Q4 2020. 832 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Cypress Point Wealth Management reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Cypress Point Wealth Management sold 480 Thermo Fisher Scientific shares in Q2 2026, an estimated $236K.
  • Cypress Point Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 2 quarters.
  • Cypress Point Wealth Management's Thermo Fisher Scientific position peaked at $582K in Q4 2020.
  • 832 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Cypress Point Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.